undamentalytics Newsletter
Sign in

Bioventus Inc. balance sheet

At the end of fiscal 2025, Bioventus Inc. had total assets of $684m, total liabilities of $455m and shareholders' equity of $184m. It held $51.2m in cash against $294m of debt: net debt of $243m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Cash and equivalents6587443037425131
Receivables—88125136123127128138
Inventory—29628591928283
Total current assets—212263273268276273266
Goodwill—5014877777
Total assets—4941,2261,373811728684673
Accounts payable—4173723241126
Deferred revenue (current)—023221—
Total current liabilities—123181304175210160158
Short-term debt—15183328271519
Long-term debt—173340385367308279211
Total debt0190358418395336294230
Total liabilities—350618960590542455382
Shareholders' equity——459325174148184240
Non-controlling interests and other (assets − liabilities − equity)——1498748384451
Net debt (negative = net cash)−65103314388358294243199

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: ATRC vs BVSBVS vs TMDXBVS vs GKOSAORT vs BVS

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Bioventus Inc.'s SEC filings (10-K and 10-Q), retrieved November 3, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Bioventus Inc.